Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture

Journal of Virology

Volumn 83, Issue 15, 2009, Pages 7457-7466

  Lace, Michael J ^a,b   Isacson, Christina ^c   Anson, James R ^a   Lörincz, Attila T ^d   Wilczynski, Sharon P ^e   Haugen, Thomas H ^a,b   Turek, Lubomír P ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN E7; REGULATOR PROTEIN; VIRUS DNA;

ARTICLE; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MAPPING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS ISOLATION; VIRUS TRANSCRIPTION;

BASE SEQUENCE; CARCINOMA; CELL LINE; CELL TRANSFORMATION, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS INFECTIONS; REGULATORY SEQUENCES, NUCLEIC ACID; REPLICATION ORIGIN; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 67650928010     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00285-09     Document Type: Article

References (67)

1. Alencar, T. R., D. M. Cerqueira, M. R. da Cruz, P. S. Wyant, E. D. Ramalho, and C. R. Martins. 2007. New HPV-16 European and non-European variants in Central Brazil. Virus Genes 35:1-4.
2. Arias-Pulido, H., C. L. Peyton, N. Torrez-Martinez, D. N. Anderson, and C. M. Wheeler. 2005. Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology 338:22-34.
3. Asadurian, Y., H. Kurilin, H. Lichtig, A. Jackman, P. Gonen, M. Tommasino, I. Zehbe, and L. Sherman. 2007. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J. Med. Virol. 79:1751-1760.
4. Baritaki, S., S. Sifakis, S. Huerta-Yepez, I. K. Neonakis, G. Soufla, B. Bonavida, and D. A. Spandidos. 2007. Overexpression of VEGF and TGF-β1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int. J. Oncol. 31:69-79.
5. Bauknecht, T., P. Angel, H. D. Royer, and H. zur Hausen. 1992. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J. 11:4607-4617.
6. Berumen, J., R. M. Ordonez, E. Lazcano, J. Salmeron, S. C. Galvan, R. A. Estrada, E. Yunes, A. Garcia-Carranca, G. Gonzalez-Lira, and A. Madriga De La Campa. 2001. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 93:1325-1330.
7. Bible, J. M., C. Mant, J. M. Best, B. Kell, W. G. Starkey, K. Shanti Raju, P. Seed, C. Biswas, P. Muir, J. E. Banatvala, and J. Cason. 2000. Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. J. Gen. Virol. 81:1517-1527.
8. Calleja-Macias, I. E., L. L. Villa, J. C. Prado, M. Kalantari, B. Allan, A. L. Williamson, L. P. Chung, R. J. Collins, R. E. Zuna, S. T. Dunn, T. Y. Chu, H. A. Cubie, K. Cuschieri, M. von KnebeDoeberitz, C. R. Martins, G. I. Sanchez, F. X. Bosch, N. Munoz, and H. U. Bernard. 2005. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J. Virol. 79:13630- 13640.
9. Cerqueira, D. M., T. Raiol, N. M. Veras, N. von Gal Milanezi, F. A. Amaral, M. de Macedo Brigido, and C. R. Martins. 2008. New variants of human papillomavirus type 18 identified in central Brazil. Virus Genes 37:282-287.
10. Chan, S. Y., L. Ho, C. K. Ong, V. Chow, B. Drescher, M. Dürst, J. ter Meulen, L. Villa, J. Luande, H. N. Mgaya, and H. U. Bernard. 1992. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol. 66:2057-2066.
11. Chen, Z., M. Terai, L. Fu, R. Herrero, R. DeSalle, and R. D. Burk. 2005. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J. Virol. 79:7014-7023.
12. Cripe, T. P., A. Alderborn, R. D. Anderson, S. Parkkinen, P. Bergman, T. H. Haugen, U. Pettersson, and L. P. Turek. 1990. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct celdependent and AP-1-responsive modules. New Biol. 2:450-463.
13. Cullen, A. P., R. Reid, M. Campion, and A. T. Lörincz. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65:606-612.
14. Dong, X. P., and H. Pfister. 1999. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16. J. Gen. Virol. 80:2097-2101.
15. Dong, X. P., F. Stubenrauch, E. Beyer-Finkler, and H. Pfister. 1994. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int. J. Cancer 58:803-808.
16. Doorbar, J. 2005. The papillomavirus life cycle. J. Clin. Virol. 32(Suppl.):7-15.
17. Dürst, M., L. Gissmann, H. Ikenberg, and H. zur Hausen. 1983. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. USA 80:3812-3815.
18. Eriksson, A., J. R. Herron, T. Yamada, and C. M. Wheeler. 1999. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J. Gen. Virol. 80:595-600.
19. Ferris, R. L., I. Martinez, N. Sirianni, J. Wang, A. Lopez-Albaitero, S. M. Gollin, J. T. Johnson, and S. Khan. 2005. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur. J. Cancer. 41:807-815.
20. Flores, E. R., and P. F. Lambert. 1997. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J. Virol. 71:7167-7179.
21. Galvin, K. M., and Y. Shi. 1997. Multiple mechanisms of transcriptional repression by YY1. Mol. Cell. Biol. 17:3723-3732.
22. Gordon, S., G. Akopyan, H. Garban, and B. Bonavida. 2005. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25:1125-1142.
23. Hafner, N., C. Driesch, M. Gajda, L. Jansen, R. Kirchmayr, I. B. Runnebaum, and M. Durst. 2008. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 27:1610-1617.
24. Haugen, T. H., M. J. Lace, T. Ishiji, A. Sameshima, J. R. Anson, and L. P. Turek. Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation. Virology, in press.
25. Hebner, C. M., and L. A. Laimins. 2006. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16:83-97.
26. Heinzel, P. A., S. Y. Chan, L. Ho, M. O'Connor, P. Balaram, M. S. Campo, K. Fujinaga, N. Kiviat, J. Kuypers, H. Pfister, et al. 1995. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J. Clin. Microbiol. 33:1746-1754.
27. Hubert, W. G. 2005. Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J. Virol. 79:5914-5922.
28. Hubert, W. G., T. Kanaya, and L. A. Laimins. 1999. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5′ of the minimal origin. J. Virol. 73:1835-1845.
29. Ishiji, T., M. J. Lace, S. Parkkinen, R. D. Anderson, T. H. Haugen, T. P. Cripe, J. H. Xiao, I. Davidson, P. Chambon, and L. P. Turek. 1992. Transcriptional enhancer factor (TEF)-1 and its celspecific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in human keratinocytes and cervical carcinoma cells. EMBO J. 11:2271-2281.
30. Jeon, S., B. L. Allen-Hoffmann, and P. F. Lambert. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:2989-2997.
31. Jeon, S., and P. F. Lambert. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92:1654-1658.
32. Kammer, C., U. Warthorst, N. Torrez-Martinez, C. M. Wheeler, and H. Pfister. 2000. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J. Gen. Virol. 81:1975-1981.
33. Kanaya, T., S. Kyo, and L. A. Laimins. 1997. The 5′ region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. Virology 237:159-169.
34. Kim, Y. B., Y. S. Song, Y. T. Jeon, J. S. Park, S. J. Um, J. W. Kim, N. H. Park, S. B. Kang, and H. P. Lee. 2005. Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women. Oncol. Rep. 14:459-464.
35. Kitagawa, K., H. Yoshikawa, T. Onda, T. Kawana, Y. Taketani, H. Yoshikura, and A. Iwamoto. 1996. Genomic organization of human papillomavirus type 18 in cervical cancer specimens. Jpn. J. Cancer Res. 87:263-268.
36. Kurvinen, K., M. Yliskoski, S. Saarikoski, K. Syrjanen, and S. Syrjanen. 2000. Variants of the long control region of human papillomavirus type 16. Eur. J. Cancer 36:1402-1410.
37. Lace, M. J., J. R. Anson, G. S. Thomas, L. P. Turek, and T. H. Haugen. 2008. The E8-E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J. Virol. 82:10841-10853.
38. Lace, M. J., J. R. Anson, L. P. Turek, and T. H. Haugen. 2008. Functional mapping of the human papillomavirus type 16 E1 cistron. J. Virol. 82:10724-10734.
39. Larkin, M. A., G. Blackshields, N. P. Brown, R. Chenna, P. A. McGettigan, H. McWilliam, F. Valentin, I. M. Wallace, A. Wilm, R. Lopez, J. D. Thompson, T. J. Gibson, and D. G. Higgins. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.
40. Lichtig, H., M. Algrisi, L. E. Botzer, T. Abadi, Y. Verbitzky, A. Jackman, M. Tommasino, I. Zehbe, and L. Sherman. 2006. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology 350:216-227.
41. Lizano, M., J. Berumen, M. C. Guido, L. Casas, and A. Garcia-Carranca. 1997. Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J. Natl. Cancer Inst. 89:1227-1231.
42. Lizano, M., and A. Garcia-Carranca. 1997. Molecular variants of human papillomaviruses types 16, 18, and 45 in tumors of the uterine cervix in Mexico. Gac. Med. Mex. 133(Suppl. 1):43-48. (In Spanish.)
43. May, M., X. P. Dong, E. Beyer-Finkler, F. Stubenrauch, P. G. Fuchs, and H. Pfister. 1994. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 13:1460-1466.
44. O'Connor, M. J., S. H. Tan, C. H. Tan, and H. U. Bernard. 1996. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J. Virol. 70:6529-6539.
45. Ong, C. K., S. Y. Chan, M. S. Campo, K. Fujinaga, P. Mavromara-Nazos, V. Labropoulou, H. Pfister, S. K. Tay, J. ter Meulen, L. L. Villa, and H. U. Bernard. 1993. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol. 67:6424-6431.
46. Pande, S., N. Jain, B. K. Prusty, S. Bhambhani, S. Gupta, R. Sharma, S. Batra, and B. C. Das. 2008. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J. Clin. Microbiol. 46:1060-1066.
47. Park, J. S., E. S. Hwang, C. J. Lee, C. J. Kim, J. G. Rha, S. J. Kim, S. E. Namkoong, and S. J. Um. 1999. Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia. Gynecol. Oncol. 74:23-29.
48. Pista, A., A. Oliveira, A. Barateiro, H. Costa, N. Verdasca, and M. T. Paixao. 2007. Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J. Med. Virol. 79:1889-1897.
49. Psyrri, A., and D. DiMaio. 2008. Human papillomavirus in cervical and head-and-neck cancer. Nat. Clin. Pract. Oncol. 5:24-31.
50. Rheinwald, J. G., and M. A. Beckett. 1981. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res. 41:1657-1663.
51. Rose, B., G. Steger, X. P. Dong, C. Thompson, Y. Cossart, M. Tattersall, and H. Pfister. 1998. Point mutations in Sp1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. J. Gen. Virol. 79:1659-1663.
52. Rose, B. R., C. H. Thompson, J. Zhang, M. Stoeter, A. Stephen, H. Pfister, M. H. Tattersall, and Y. E. Cossart. 1997. Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol. Oncol. 66:282-289.
53. Schmidt, M., W. Kedzia, and A. Gozdzicka-Jozefiak. 2001. Intratype HPV16 sequence variation within LCR of isolates from asymptomatic carriers and cervical cancers. J. Clin. Virol. 23:65-77.
54. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114.
55. Shi, Y., J. S. Lee, and K. M. Galvin. 1997. Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332:F49-F66.
56. Stephen, A. L., C. H. Thompson, M. H. Tattersall, Y. E. Cossart, and B. R. Rose. 2000. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int. J. Cancer 86:695-701.
57. Swan, D. C., M. Rajeevan, G. Tortolero-Luna, M. Follen, R. A. Tucker, and E. R. Unger. 2005. Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol. Oncol. 96:695-700.
58. Tornesello, M. L., M. L. Duraturo, S. Losito, G. Botti, S. Pilotti, B. Stefanon, G. De Palo, A. Gallo, L. Buonaguro, and F. M. Buonaguro. 2008. Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int. J. Cancer 122:132-137.
59. Ushikai, M., M. J. Lace, Y. Yamakawa, M. Kono, J. Anson, T. Ishiji, S. Parkkinen, N. Wicker, M. E. Valentine, I. Davidson, L. P. Turek, and T. H. Haugen. 1994. trans activation by the fullength E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. J. Virol. 68:6655-6666.
60. Veress, G., M. Murvai, K. Szarka, A. Juhasz, J. Konya, and L. Gergely. 2001. Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. Eur. J. Cancer. 37:1946-1952.
61. Villa, L. L., L. Sichero, P. Rahal, O. Caballero, A. Ferenczy, T. Rohan, and E. L. Franco. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 81:2959-2968.
62. Weill, L., E. Shestakova, and E. Bonnefoy. 2003. Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. J. Virol. 77:2903-2914.
63. Wooldridge, T. R., and L. A. Laimins. 2008. Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. Virology 374:371-380.
64. Xi, L. F., N. B. Kiviat, A. Hildesheim, D. A. Galloway, C. M. Wheeler, J. Ho, and L. A. Koutsky. 2006. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J. Natl. Cancer Inst. 98:1045-1052.
65. Xi, L. F., L. A. Koutsky, A. Hildesheim, D. A. Galloway, C. M. Wheeler, R. L. Winer, J. Ho, and N. B. Kiviat. 2007. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol. Biomarkers Prev. 16:4-10.
66. Yamada, T., M. M. Manos, J. Peto, C. E. Greer, N. Munoz, F. X. Bosch, and C. M. Wheeler. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71:2463-2472.
67. Yamada, T., C. M. Wheeler, A. L. Halpern, A. C. Stewart, A. Hildesheim, and S. A. Jenison. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 69:7743-7753.